Private equity firm to buy Summa Health for $485M

Ohio-based Summa Health confirms its acquisition by a private equity firm, nearly a year after the buyout was initially proposed.

According to an announcement, venture capital firm General Catalyst will purchase the 1,300-bed health system for $485 million. Once the deal is approved by regulators, Summa Health will operate under the banner of General Catalyst’s Health Assurance Transformation business (HATco), which includes a network of some 20 health systems. 

HATco has pledged to invest $550 million in Summa Health over the next seven years to bolster routine operations and support technology investments. The sale will also wipe out the existing debt of Summa Health, which totals around $850 million.

It’s not entirely clear how business operations at Summa Health, a nonprofit, will change. However, in its announcement, the health system said it will “maintain its charity care policy, community benefit, and essential services” while focusing on growth and expansion. 

“As part of HATCo, Summa Health will be better positioned to build upon our existing strengths and capabilities while also benefiting from new opportunities and technology. Our goals are to expand access to care and improve the experience for our patients, providers and staff,” Cliff Deveny, M.D., Summa Health President and CEO, said in the announcement. 

Any remaining cash Summa Health has available after paying its creditors will be used to fund a new “separately governed community foundation” to make investments in the greater Akron, Ohio, area, the organization said. It also noted that HATCo is committed to making long-term investments in the community.

In addition to healthcare, General Catalyst’s portfolio includes investments in consumer technology, artificial intelligence, hospitality and defense. 

HATCo and Summa Health are awaiting approval from the Federal Trade Commission, the Ohio Attorney General’s office and the Ohio Department of Insurance before the sale becomes official. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”